Home › Funds › BALANCE CAPITAL PARTNERS L.P. › DNA

BALANCE CAPITAL PARTNERS L.P. position in DNA

GINKGO BIOWORKS HOLDINGS INC · Health Care

BALANCE CAPITAL PARTNERS L.P. reported holding 199,009 shares of DNA (GINKGO BIOWORKS HOLDINGS INC) in its Q2 2026 13F filing — a position valued at US$2.0M, representing 1.42% of its reported portfolio and ranking #10 among its reported holdings. BALANCE CAPITAL PARTNERS L.P. first reported this position in Q2 2026.

Latest position (Q2 2026)199.01K sh
Reported value held$1.97M
Portfolio Weight1.42%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BALANCE CAPITAL PARTNERS L.P.'s DNA position evolved

BALANCE CAPITAL PARTNERS L.P. first disclosed a stake in DNA in Q2 2026 at 199,009 shares (US$2.0M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 199.01K $1.97M New

About DNA and 13F data

DNA (GINKGO BIOWORKS HOLDINGS INC) is a Health Care company. 33 other funds we track also report a position in DNA — the largest reported positions include Anchorage Capital Group, L.L.C. (US$17.3M), FORBES J M & CO LLP (US$12.5M), SB INVESTMENT ADVISERS (UK) LTD (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNA

All DNA fund holders →

FAQ

How long has BALANCE CAPITAL PARTNERS L.P. held DNA?

BALANCE CAPITAL PARTNERS L.P. has disclosed DNA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is BALANCE CAPITAL PARTNERS L.P.'s current position in DNA?

As of Q2 2026, BALANCE CAPITAL PARTNERS L.P. holds 199.01K shares of DNA (GINKGO BIOWORKS HOLDINGS INC), valued at $1.97M, representing 1.42% of its reported portfolio and ranking #10.

Has BALANCE CAPITAL PARTNERS L.P. been buying or selling DNA?

In the latest 13F filing (Q2 2026), BALANCE CAPITAL PARTNERS L.P. newly opened its position in DNA.

Which other funds hold DNA?

Other major institutional holders of DNA include Anchorage Capital Group, L.L.C., FORBES J M & CO LLP, SB INVESTMENT ADVISERS (UK) LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.